GNPX
Genprex, Inc.
Industry
Biotechnology
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Loading...
Open
1.07
Mkt cap
9.9M
Volume
2M
High
1.23
P/E Ratio
-0.11
52-wk high
14.40
Low
1.07
Div yield
N/A
52-wk low
0.28

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.